BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li DD, Yu P, Xiao W, Wang ZZ, Zhao LG. Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs. Curr Top Med Chem 2020;20:2634-47. [PMID: 32901585 DOI: 10.2174/1568026620666200908165913] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Li S, Zhang Y, Wang Y, Yuan L, Kong C, Xiao Z, Zhu H. Identification of (N-aryl-N-arylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors and the mechanism exploration. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.106275] [Reference Citation Analysis]
2 Zhang S, Zhao Y, Tan L, Wu S, Zhang Q, Zhao B, Li G. A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats. Front Pharmacol 2022;13:891829. [DOI: 10.3389/fphar.2022.891829] [Reference Citation Analysis]
3 Song K, Sun Y, Liu H, Li Y, An N, Wang L, Zhang H, Yang F, Xing Y, Gao Y. Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Berberine in the Treatment of Ischaemic Stroke. Evid Based Complement Alternat Med 2022;2022:5160329. [PMID: 35815278 DOI: 10.1155/2022/5160329] [Reference Citation Analysis]
4 Auth PA, da Silva GR, Amaral EC, Bortoli VF, Manzano MI, de Souza LM, Lovato ECW, Ribeiro-Paes JT, Gasparotto Junior A, Lívero FADR. Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats. Front Pharmacol 2022;13:886122. [PMID: 35668935 DOI: 10.3389/fphar.2022.886122] [Reference Citation Analysis]
5 Kong Y, Yi Y, Liu X, Yu P, Zhao L, Li D. Discovery and structural optimization of 9-O-phenylsulfonyl-berberines as new lipid-lowering agents. Bioorganic Chemistry 2022;121:105665. [DOI: 10.1016/j.bioorg.2022.105665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kong Y, Li L, Zhao LG, Yu P, Li DD. A patent review of berberine and its derivatives with various pharmacological activities (2016-2020). Expert Opin Ther Pat 2021. [PMID: 34455891 DOI: 10.1080/13543776.2021.1974001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Patel P. A bird's eye view on a therapeutically ‘wonder molecule’: Berberine. Phytomedicine Plus 2021;1:100070. [DOI: 10.1016/j.phyplu.2021.100070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Feng G, Ma G, Chen W, Xu S, Wang K, Wang S. Asymmetric Synthesis of Tetrahydroisoquinoline Derivatives through 1,3-Dipolar Cycloaddition of C,N-Cyclic Azomethine Imines with Allyl Alkyl Ketones. Molecules 2021;26:2969. [PMID: 34067645 DOI: 10.3390/molecules26102969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Meng Q, Zhang L, Zhu X, Teng Q. Synthesis of 9‐O‐Arylated Berberine with a Polystyrene Resin Supported Copper(II) Catalyst. ChemistrySelect 2021;6:4011-4014. [DOI: 10.1002/slct.202100525] [Reference Citation Analysis]
10 Gladkova ED, Chepanova AA, Ilina ES, Zakharenko AL, Reynisson J, Luzina OA, Volcho KP, Lavrik OI, Salakhutdinov NF. Discovery of Novel Sultone Fused Berberine Derivatives as Promising Tdp1 Inhibitors. Molecules 2021;26:1945. [PMID: 33808389 DOI: 10.3390/molecules26071945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Duan Y, Zhu HL. Privileged Scaffolds for Drug Design and Activity Improvement-Part I. Curr Top Med Chem 2020;20:2519. [PMID: 33241777 DOI: 10.2174/156802662028201021110151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]